Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/1998
08/13/1998WO1998034631A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034614A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
08/13/1998WO1998034611A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998WO1998034602A2 Mediation of cytokines by melanin
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998018466A3 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/13/1998CA2281699A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998CA2280195A1 Synthetic hiv gag genes
08/13/1998CA2280140A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998CA2280048A1 Il-8 receptor antagonists
08/13/1998CA2279995A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998CA2279946A1 Mediation of cytokines by melanin
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2253221A1 Bi-aromatic compounds, compositions containing them and uses
08/12/1998EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus
08/12/1998EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857732A1 Human pec-60-like protein and dna encoding the same
08/12/1998EP0857486A2 Mixture of external membranes and/or cell wall from bacteria for oral immunisation against mucosal infections
08/12/1998EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption
08/12/1998EP0857061A1 Solubilisation methods
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/12/1998EP0689538B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/12/1998EP0639071B1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil
08/12/1998EP0636177B1 Isolation, characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin e
08/12/1998CN1190394A Bicyclic-aromatic compound
08/12/1998CN1190393A Diaryldiamine derivatives and their use as delta opioid (ANT)-agonists
08/12/1998CN1190390A Nitric oxide synthase inhibitors derived from cyclic amidines
08/12/1998CN1190096A Compounds analogous to thalidomide from class comprising piperidine-2,6-diones
08/11/1998US5792882 5-lipoxygenase inhibitors, antiallergens, antiinflammatory agents
08/11/1998US5792850 Isolated polynucleotide encoding a polypeptide as a stimulant ligand-binding receptor
08/11/1998US5792834 Polyethylene-protein conjugates
08/11/1998US5792784 A pseudo-dipeptide product which is histamine or methyl-substituted histamine coupled with a amino acid; used in therapeutical, cosmetological applications and treats vision defect
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792770 Administering as sedative, tranquilizer, anxiolytic agent
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792629 Nucleotide and amino acid sequences
08/11/1998US5792626 Human interferon-inducible protein
08/11/1998US5792620 Cloning and expression of human islet glutamic acid decarboxylase autoantigen
08/11/1998US5792506 Disulfide bonds are reduced to sulfhydryl decreasing allergenicity of feeds
08/11/1998US5792463 Hybrid particle immunogens
08/11/1998US5792457 Antibody recognizing endothelial cell ligand for leukocyte CR3
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033811A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998WO1998033789A1 Synthesis of terfenadine and derivatives
08/06/1998WO1998033788A1 Matrix metalloproteinase inhibitors
08/06/1998WO1998033528A2 Induction of b cell tolerance
08/06/1998WO1998033522A1 Infectious bursitis vaccine
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033512A1 Oil-free pharmaceutical compositions containing cyclosporin a
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
08/06/1998WO1998023959A3 Diagnosis and treatment of insulin-dependent diabetes mellitus
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998CA2279544A1 Induction of b cell tolerance
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2278847A1 Method for the production of selected lymphocytes
08/06/1998CA2278824A1 Infectious bursitis vaccine
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998CA2278675A1 Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
08/06/1998CA2278638A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998CA2278595A1 Secreted proteins and polynucleotides encoding them
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856579A1 An antisense oligonucleotide preparation method
08/05/1998EP0856520A1 Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
08/05/1998EP0856513A2 Thalidomide analogues from the piperidine-2,6-dione class
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856009A1 Cd6 ligand
08/05/1998EP0856005A1 The aiolos gene
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0752990B1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
08/05/1998EP0722452A4 Nf-at polypeptides and polynucleotides
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998CN1189837A Peptide and method of obtaining it
08/05/1998CN1189829A Piperazino derivatives as neurokinin antagonists
08/05/1998CN1189491A Isoxazole and crotonamide derivatives and their use as pharmaceuticals and disgnositics
08/05/1998CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789605 Discodermolides; anticarcinogenic agents; immunosuppressants; sponges; reacting a 1,3-dioxanyl-containing phosphonium salt with a base and furan-containing alkyl thiol
08/04/1998US5789573 Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
08/04/1998US5789567 Chicken infectious anemia virus vaccine
08/04/1998US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/04/1998US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/04/1998US5789433 Green porphyrins as immunomodulators
08/04/1998US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them
08/04/1998US5789192 Mammalian receptors for interleukin-10 (IL-10)
08/04/1998US5788985 Comprising n-glycidyl ganglioside coupled to carier protein, adjuvant
08/04/1998US5788969 Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus
08/04/1998US5788968 Oral administration of major histocompatibility complex antigen
1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 1172